STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients

DSpace/Manakin Repository

Title:	STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients
Author:	Srivastava, Raghvendra M; Jie, Hyun-bae; Ferrone, Soldano; Ferris, Robert L Note: Order does not necessarily reflect citation order of authors.
Citation:	Srivastava, Raghvendra M, Hyun-bae Jie, Soldano Ferrone, and Robert L Ferris. 2013. “STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients.” Journal for Immunotherapy of Cancer 1 (Suppl 1): P175. doi:10.1186/2051-1426-1-S1-P175. http://dx.doi.org/10.1186/2051-1426-1-S1-P175.
Full Text & Related Files:	3991086.pdf (140.1Kb; PDF)
Abstract:
Published Version:	doi:10.1186/2051-1426-1-S1-P175
Other Sources:	http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991086/pdf/
Terms of Use:	This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page:	http://nrs.harvard.edu/urn-3:HUL.InstRepos:12407007
Downloads of this work: